KRAS and neoplasm: They observed a higher rate of KRAS mutation in the tumor center compared with the front invasion, suggesting that tumor samples should be preferably taken from the tumor center, while no information was given if the profiling differed between both superficial and deep primary tumor sectors [5, 6].